You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
A Heterologous Prime-Boost Vaccination Regimen Using ORFF DNA and Recombinant ORFF Protein Confers Protective Immunity against Experimental Visceral Leishmaniasis
Poonam Tewary, Manju Jain, Mayurbhai H. Sahani, Shailendra Saxena and Rentala Madhubala
The Journal of Infectious Diseases
Vol. 191, No. 12 (Jun. 15, 2005), pp. 2130-2137
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30077877
Page Count: 8
Preview not available
Objective. We describe the effectiveness of a prime-boost vaccination regimen using the open-reading frame (ORFF) gene from the LD1 locus of Leishmania donovani. Methods. A group of BALE/c mice was immunized with the plasmid carrying the gene for ORFF (F/pcDNA 3.1) and given a booster dose of either the same DNA vaccine or a vaccine with a recombinant ORFF (rORFF) protein. Another group of BALE/c mice was immunized and given a booster dose of the rORFF protein vaccine. The protective efficacies of these vaccine formulations were compared after challenge with L. donovani stationary-phase promastigotes. Results. Mice given the prime-boost vaccination regimen had an enhanced reduction in parasite load (75%-80%), compared with that in mice given only the rORFF protein vaccine (45%-60%). However, the protective response induced in the prime-boost group was not more than that elicited in the DNA vaccine group. Immunization with only the rORFF protein vaccine did not induce the typical T helper response, whereas priming with the DNA vaccine resulted in enhanced production of immunoglobulin G2a and interferon-γ. Furthermore, priming with the DNA vaccine also led to enhanced proliferation of splenocytes, suggesting subsequent expansion of antigen-specific T cells. Conclusions. The heterologous prime-boost vaccination strategy may be utilized for visceral leishmaniasis.
The Journal of Infectious Diseases © 2005 Oxford University Press